agilon health (NYSE:AGL – Free Report) had its price target raised by TD Cowen from $3.50 to $6.00 in a research report released on Tuesday,Benzinga reports. They currently have a hold rating on the stock.
Several other research analysts have also issued reports on the stock. Robert W. Baird decreased their price target on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a report on Friday, March 21st. Finally, Stifel Nicolaus lifted their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, agilon health presently has an average rating of “Hold” and a consensus price target of $4.60.
Get Our Latest Stock Analysis on agilon health
agilon health Stock Performance
Hedge Funds Weigh In On agilon health
A number of institutional investors have recently bought and sold shares of AGL. Oak Thistle LLC purchased a new position in agilon health in the 4th quarter valued at approximately $25,000. Ieq Capital LLC purchased a new stake in agilon health during the 4th quarter valued at approximately $26,000. Signaturefd LLC increased its stake in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after acquiring an additional 8,467 shares during the period. Humankind Investments LLC purchased a new stake in shares of agilon health during the 4th quarter worth $30,000. Finally, Raymond James Financial Inc. purchased a new position in agilon health in the 4th quarter valued at approximately $33,000.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
- Five stocks we like better than agilon health
- What is a Death Cross in Stocks?
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.